England confronts a surge in antibiotic-resistant gonorrhea cases, even as overall diagnoses dip. The UK Health Security agency reports a troubling rise in drug-resistant strains, despite a 16% decrease in total gonorrhea cases during 2024. Ceftriaxone, the primary treatment, faces growing resistance, with travel-linked cases from the Asia-Pacific region contributing to the problem. The news … Read more
Supplemental imaging techniques could more than triple cancer detection in dense breasts compared with standard care alone, according to new research. The study, published in The Lancet, found that abbreviated magnetic resonance imaging (AB-MRI) and contrast-enhanced mammography (CEM) could help detect an additional 3500 breast cancer cases per year in the UK. Around 2.2 million … Read more
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several changes to the way the antibiotic azithromycin is used in the EU, including the removal of certain indications. The recommendations aim to optimize the use of the antibiotic and minimize the development of antimicrobial resistance, CHMP said. CHMP’s review and re-evaluation of … Read more
Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours The test, called ROBIN, uses PromethION nanopore sequencing to deliver rapid methylome classification. The researchers said results could be available intraoperatively, allowing clinicians to make faster, more informed decisions. The same assay … Read more
TOPLINE: Early introduction of atorvastatin vs placebo in patients with hypertension demonstrated significant benefits in reducing cardiovascular disease events, such as non-fatal myocardial infarction (MI) and coronary heart disease (CHD) events, over a 20-year follow-up period. METHODOLOGY: Researchers analysed data from the ASCOT lipid-lowering arm study and included 4605 UK participants with hypertension, at least … Read more
The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS). This decision makes the NHS the first healthcare system in Europe to widely offer the at-home tablet for patients with active MS. The final draft guidance means cladribine is an option for … Read more
Among more than 3000 men from low-income communities who were screened for various health issues at mobile clinics, one had stage IV and none had metastatic prostate cancer. These were among the findings of a study presented by lead author Masood Moghul, MBBS, at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium … Read more